4.6 Review Book Chapter

Quantitative Molecular Positron Emission Tomography Imaging Using Advanced Deep Learning Techniques

Journal

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-bioeng-082420-020343

Keywords

artificial intelligence; machine learning; deep learning; molecular imaging; quantification

Funding

  1. Swiss National Science Foundation [SNRF 320030_176052]
  2. Eurostars Programme of the European Commission [E!12326]
  3. Private Foundation of Geneva University Hospitals [RC-06-01]
  4. US National Institutes of Health [R37-CA222215, R01-CA233487]

Ask authors/readers for more resources

The past decade has seen a growing interest in quantitative molecular imaging using ML/DL techniques, covering various steps from basic principles to obtaining quantitatively accurate PET data. This includes algorithms for denoising or correcting physical degrading factors, as well as quantifying tracer uptake and metabolic tumor volume for treatment monitoring or radiation therapy planning and response prediction. Challenges and opportunities for the adoption of ML/DL approaches in multimodality imaging are also discussed in this review.
The widespread availability of high-performance computing and the popularity of artificial intelligence (AI) with machine learning and deep learning (ML/DL) algorithms at the helm have stimulated the development of many applications involving the use of AI-based techniques in molecular imaging research. Applications reported in the literature encompass various areas, including innovative design concepts in positron emission tomography (PET) instrumentation, quantitative image reconstruction and analysis techniques, computer-aided detection and diagnosis, as well as modeling and prediction of outcomes. This review reflects the tremendous interest in quantitative molecular imaging using ML/DL techniques during the past decade, ranging from the basic principles of ML/DL techniques to the various steps required for obtaining quantitatively accurate PET data, including algorithms used to denoise or correct for physical degrading factors as well as to quantify tracer uptake and metabolic tumor volume for treatment monitoring or radiation therapy treatment planning and response prediction. This review also addresses future opportunities and current challenges facing the adoption of ML/DL approaches and their role in multimodality imaging.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available